Search Results 421-430 of 18828 for Neutrophil

1. Clinical trials - Oncology (Medical)

   MC1733, Phase I Trial of Intratumoral Administration of a Measles Virus Derivative Expressing the Helicobacter pylori Neutrophil-activating Protein (NAP) ...

2. A Study to Evaluate the Effectiveness and Safety of P276-00 for Mantle Cell Lymphoma that has Returned and/or is Resistant to Treatment - Mayo Clinic

   Absolute neutrophil count <1000/mm3; Platelet count <50,000/mm3; Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) >3 × institutional upper ...

3. Low white blood cell count When to see a doctor - Mayo Clinic

   In general, for adults, a count lower than 3,500 white blood cells per microliter of blood is considered low. For children, an expected count depends on the age ...

4. A Study to Evaluate the Safety and Effectiveness of Upadacitinib (ABT-494) in Subjects with Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Absolute neutrophil count < 1200/µL;; Absolute lymphocyte count < 750/µL. Participating Mayo Clinic locations. Study statuses change often. Please contact the ...

5. A Phase I/II, open-label, multi-center trial of [177Lu]Lu-NeoB in combination with capecitabine in adult patients with GRPR+, ER+, HER2- metastatic breast cancer after progression on previous endocrine therapy in combination with a CDK4/6 inhibito - Mayo Clinic

   Absolute neutrophil count ≥ 1.5 × 10^9 /L;; Platelets ≥ 100 × 10^9 /L;; Hemoglobin ≥ 9.0 g/dL;; International Normalized Ratio (INR) ≤ 1.5;; Creatinine ...

6. A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or Without the Novel Genomic Biomarker, DGM1 - Mayo Clinic

   Absolute neutrophil count (ANC) ≥ 1.5 x 10^9/L;; Platelets count ≥ 100 x 10^9/L;; Hemoglobin ≥ 10 g/dL (eligibility level for hemoglobin may be met by ...

7. A Study of BBI608 Administered With Paclitaxel in Adult Patients With Advanced Malignancies - Mayo Clinic

   Absolute neutrophil count ³ 1.5 x 109/L; Platelets ≥ 100 x 109/L; Life expectancy ≥ 3 months. Exclusion Criteria: Anti-cancer chemotherapy, radiotherapy ...

8. Pembrolizumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Merkel Cell Cancer - Mayo Clinic

   Absolute neutrophil count (ANC) >= 1,500/mm^3; Platelet count >= 100,000/mm^3; Hemoglobin >= 9.0 g/dl; Total bilirubin =< 2.0 mg/dl; Aspartate aminotransferase ...

9. Combination Chemotherapy in Treating Younger Patients with Newly Diagnosed, Non-Metastatic Desmoplastic Medulloblastoma - Mayo Clinic

   Peripheral absolute neutrophil count (ANC) ≥ 1000/uL; Platelet count ≥ 100,000/uL (transfusion independent); Hemoglobin ≥ 10.0 g/dL (may receive red blood ...

10. LS1681: A Study of AR160 in Treating Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma - Mayo Clinic

    Absolute neutrophil count (ANC) ≥ 1500/mm^3. Platelet count ≥ 75,000/mm^3. Hemoglobin ≥ 8.0g/dL. Total bilirubin ≤ 1.5 x upper limit of normal (ULN) or ...